Enzyme replacement therapy extends survival in Pompe disease About.com
Type II glycogen storage disorder, also known as Pompe disease, is caused by a deficiency of the enzyme GAA. Myozyme (alglucosidase alfa), marketed by Genzyme, replaces the missing enzyme. Researchers
Family In Need Of Van With Wheelchair Lift Given Generous Gift WHIO-TV 7 Dayton
ANNA, Ohio -- There were tears, hugs and disbelief for an Anna family of five in need of a van equipped with a wheelchair lift, when one was found parked in a family member's driveway Friday night.
Amicus Therapeutics Commences Phase 1 Clinical Trials For AT2220 For Pompe Disease Medical News Today
Amicus Therapeutics, a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment of human genetic diseases, today announced that it has commenced Phase 1 clinical trials for AT2220 for the treatment of Pompe disease, following acceptance of an investigational new drug application (IND) by the U.S. [click link for full article]
Frères musulmans Al-Ahram Hebdo
Alors que l’Etat vient d’effectuer les rafles les plus importantes dans les rangs de la confrérie depuis une dizaine d’années, un pas supplémentaire a été franchi : pour la première fois, l’accusation de terrorisme est retenue
Treatment Discovered For Deadly Childhood Disease Science Daily
Researchers have discovered that a treatment involving enzyme replacement therapy dramatically reduces the risk of death in children with Pompe disease, a rare genetic disorder in which most children die before their first birthday. The disorder causes profound muscle weakness and heart and breathing problems and affects as many as one in 40,000 births. The study is published in the online
Treatment Discovered For Deadly Childhood Disease Medical News Today
Researchers have discovered that a treatment involving enzyme replacement therapy dramatically reduces the risk of death in children with Pompe disease, a rare genetic disorder in which most children die before their first birthday. The disorder causes profound muscle weakness and heart and breathing problems and affects as many as one in 40,000 births. [click link for full article]
MEDIA - France 24 entre dans la danse mondiale de l’actu le petit journal
Jacques Chirac va peut être se mettre à croire au père Noël. La chaîne internationale, dont il rêvait depuis 1987, va enfin voir le jour. Ce soir, à 20h29 exactement, France 24 investit le monde pour lui offrir un regard français sur l’actualité
LA FRANCE CONFISQUEE! Indymedia Chiapas
La France confisquée !… « Laïcité », racisme et terrorisme… Préférences et détestations communautaires de l’Etat français…. La politique de la France serait-elle définie par le CRIF et ses filiales ?
New Therapy for Kids With Pompe Disease RedNova
Enzyme replacement therapy created by U.S. researchers extends life in kids with Pompe disease, a rare genetic disorder usually fatal by age one. Pompe disease occurs in as many as one in 40,000 births and causes profound muscle weakness, heart, and breathing problems.
Treatment discovered for deadly childhood disease EurekAlert!
ST. PAUL, Minn -- Researchers have discovered that a treatment involving enzyme replacement therapy dramatically reduces the risk of death in children with Pompe disease, a rare genetic disorder in which most children die before their first birthday.
pompe: pompe a essence | pompe a vide | pompe a essence | pompe a vide | pompe